“I strongly believe that talent and potential are everywhere, but opportunity often isn’t. When I learned about the UMB CURE Scholars Program, I was impressed by the comprehensive nature of the program, the students’ commitment to it, and the quantifiable metrics proving that investment like this in young talent works.
“The focus on STEM careers made it a great fit, intersecting my interest in making an impact personally with my professional work. I’ve worked in the health care field with technologies that impact cancer care and other diseases for nearly 20 years, and we need a pipeline of diverse talent to solve the many health care challenges we face.”
— Megan Bailey, MPH
Megan Bailey, MPH, is the former chief executive officer (CEO) of Personal Genome Diagnostics (PGDx), a biotech company providing revolutionary comprehensive genomic profiling solutions and services for oncology patients to improve the standard of cancer care for all. She recently led the acquisition of PGDx by Labcorp and now serves as chief of staff to the Labcorp CEO. Bailey has more than two decades of experience in the health care industry and leads with a deep understanding of the impact personalized testing and treatment has on outcomes for patients and their families. She is a graduate of the U.S. Military Academy at West Point and earned her Master of Public Health degree from the University of North Carolina at Chapel Hill.
Read more in the July/August 2022 issue of SPOTLIGHT newsletter.
Don’t miss the current issue of SPOTLIGHT newsletter featuring compelling stories that connect philanthropy and UMB’s Catalyst Campaign to newsworthy events and milestones happening across the University.